Estrace combined with Estraderm

Reports:

Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
Breast Cancer Female Other Serious Female 1/31/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/21/1999 74 Female 2/6/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 9/30/2001 Female 12/23/2005 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 1/21/1999 74 Female 2/7/2006 United States
Primary
Secondary
Breast Cancer Other Serious 10/1/2001 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 8/20/2002 56 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/1998 42 Female 170 lb 3/7/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 12/3/1996 68 Female 3/27/2006 Consumer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 12/3/1996 68 Female 3/28/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 10/1/2001 Female 2/8/2006 Consumer United States
Primary
Secondary
Neoplasm Malignant Other Serious 12/14/1995 54 Female 190 lb 4/18/2006 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 6/26/2001 73 Female 5/24/2006 Consumer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 6/26/2001 73 Female 5/24/2006 United States
Primary
Secondary
Breast Cancer Other Serious 10/1/2001 Female 6/8/2006 Consumer United States
Primary
Secondary
Ovarian Cancer Metastatic Other Serious 8/1/2002 59 Female 162 lb 7/12/2006 Lawyer United States
Primary
Secondary
Concomitant
Ovarian Cancer Metastatic Other Serious 8/1/2002 59 Female 162 lb 7/26/2006 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 8/9/1994 57 Female 125 lb 10/10/2006 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 10/28/1999 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer In Situ Other Serious 12/3/1996 68 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 9/7/1999 51 Female 10/10/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 7/6/1999 67 Female 9/18/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 9/30/2001 Female 9/18/2006 Lawyer United States
Primary
Secondary
Injury Other Serious 10/1/2001 Female 9/18/2006 Lawyer United States
Primary
Secondary
Oestrogen Receptor Assay Positive Other Serious 6/26/2001 73 Female 9/18/2006 Lawyer United States
Primary
Secondary
Injury Other Serious 10/28/1999 9/18/2006 Lawyer United States
Primary
Secondary
Tachycardia Other Serious 8/9/1994 57 Female 125 lb 3/1/2007 United States
Primary
Secondary
Concomitant
Visual Disturbance Other Serious 1/1/1998 55 Female 3/1/2007 United States
Primary
Secondary
Concomitant
Weight Increased Other Serious 1/1/1985 57 Female 155 lb 3/27/2007 Physician United States
Primary
Secondary
Concomitant
Vaginal Infection Other Serious 2/1/1993 59 Female 212 lb 3/27/2007 United States
Primary
Secondary
Concomitant
Ultrasound Breast Abnormal Other Serious 1/1/2000 60 Female 180 lb 3/28/2007 Lawyer United States
Primary
Secondary
Concomitant
Spondylitis Other Serious 1/1/1992 65 Female 143 lb 4/3/2007 Physician United States
Primary
Secondary
Vertigo Positional Other Serious 12/3/1997 60 Female 150 lb 4/5/2007 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 8/20/1998 56 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 6/26/2001 73 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 8/20/2002 54 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/21/1999 74 Female 12/22/2006 United States
Primary
Secondary
Weight Increased Other Serious 8/5/1994 56 Female 130 lb 4/14/2007 United States
Primary
Secondary
Concomitant
Radiotherapy Other Serious 4/22/1994 57 Female 135 lb 5/10/2007 United States
Primary
Secondary
Concomitant
Irritable Bowel Syndrome Other Serious 7/7/1998 65 Female 185 lb 2/7/2007 Physician United States
Primary
Secondary
Concomitant
Uterine Leiomyoma Other Serious 1/1/1995 67 Female 5/30/2007 Lawyer United States
Primary
Secondary
Uterine Leiomyoma Other Serious 1/1/1997 56 Female 140 lb 6/5/2007 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious Female 4/6/2007 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Rectal Polypectomy Other Serious 1/1/1997 53 Female 105 lb 6/26/2007 United States
Primary
Secondary
Uterine Dilation And Curettage Other Serious 8/1/1990 62 Female 220 lb 6/30/2007 United States
Primary
Secondary
Concomitant
Breast Cancer Stage Ii Other Serious 1/1/1998 48 Female 7/26/2007 Consumer United States
Primary
Secondary
Concomitant
Visual Disturbance Other Serious 5/1/1993 56 Female 160 lb 8/4/2007 United States
Primary
Secondary
Concomitant
Uterine Polyp Other Serious 1/3/1996 53 Female 150 lb 8/4/2007 Physician United States
Primary
Secondary
Weight Increased Other Serious 2/1/1991 73 Female 150 lb 8/18/2007 United States
Primary
Secondary
Concomitant
Ureteric Obstruction Other Serious 12/28/1993 67 Female 115 lb 8/24/2007 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 1/21/1999 74 Female 10/8/2007 Consumer United States
Primary
Secondary
Ultrasound Breast Abnormal Other Serious 1/1/2000 11/3/2007 United States
Primary
Secondary
Concomitant
Uterine Leiomyoma Other Serious 1/1/1992 65 Female 143 lb 11/7/2007 Physician United States
Primary
Secondary
Transient Ischaemic Attack Other Serious 4/25/2000 Female 11/13/2007 Lawyer United States
Primary
Secondary
Vertigo Positional Other Serious 12/3/1997 11/15/2007 United States
Primary
Secondary
Concomitant
Weight Increased Other Serious 8/5/1994 11/15/2007 United States
Primary
Secondary
Concomitant
Tonsillectomy Other Serious 1/1/1992 67 Female 112 lb 11/15/2007 United States
Primary
Secondary
Concomitant
Uterine Leiomyoma Other Serious 4/13/1998 52 Female 225 lb 9/17/2007 Lawyer United States
Primary
Secondary
Concomitant
Unevaluable Event Other Serious 1/1/1992 67 Female 112 lb 9/17/2007 Lawyer United States
Primary
Secondary
Concomitant
Metrorrhagia Other Serious 12/1/1994 55 Female 9/17/2007 Lawyer United States
Primary
Secondary
Concomitant
Uterine Leiomyoma Other Serious 3/19/1998 51 Female 160 lb 9/17/2007 Physician United States
Primary
Secondary
Concomitant
Pain Other Serious 5/1/1996 48 Female 124 lb 9/17/2007 Physician United States
Primary
Secondary
Concomitant
Vaginoplasty Other Serious 1/1/1995 67 Female 11/29/2007 United States
Primary
Secondary
Radius Fracture Other Serious 5/1/1996 48 Female 124 lb 12/3/2007 United States
Primary
Secondary
Concomitant
Vomiting Other Serious 1/1/1997 54 Female 127 lb 12/3/2007 United States
Primary
Secondary
Concomitant
Rectal Polypectomy Other Serious 1/1/1997 53 Female 105 lb 12/4/2007 United States
Primary
Secondary
Breast Cancer Stage Ii Other Serious 1/1/1998 48 Female 12/21/2007 Consumer United States
Primary
Secondary
Concomitant
Weight Increased Other Serious 2/1/1991 73 Female 150 lb 1/23/2008 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 9/13/2001 65 Female 12/18/2007 United States
Primary
Secondary
Breast Cancer Other Serious 3/25/2003 57 Female 12/18/2007 United States
Primary
Secondary
Breast Cancer Other Serious 7/1/2002 Female 12/18/2007 United States
Primary
Secondary
Breast Cancer Other Serious 2/27/1997 55 Female 12/18/2007 United States
Primary
Secondary
Pulmonary Embolism Other Serious 11/5/2001 58 Female 12/18/2007 United States
Primary
Secondary
Spinal Cord Disorder Other Serious 1/1/1997 53 Female 105 lb 3/27/2008 United States
Primary
Secondary
Concomitant
Surgery Other Serious 5/3/1998 52 Female 155 lb 3/27/2008 United States
Primary
Secondary
Concomitant
Ovarian Cancer Metastatic Other Serious 8/1/2002 59 Female 163 lb 7/20/2006 Lawyer United States
Primary
Secondary
Concomitant
Vaginoplasty Other Serious 1/1/1995 67 Female 4/8/2008 United States
Primary
Secondary
Vaginoplasty Other Serious 1/1/1995 67 Female 4/8/2008 United States
Primary
Secondary
Weight Increased Other Serious 2/1/1991 73 Female 150 lb 4/8/2008 United States
Primary
Secondary
Concomitant
Uterine Polyp Other Serious 1/3/1996 52 Female 150 lb 4/23/2008 United States
Primary
Secondary
Contralateral Breast Cancer Other Serious 3/23/1999 Female 5/2/2008 Consumer United States
Primary
Secondary
Uterine Haemorrhage Other Serious 4/25/2000 Female 5/7/2008 Lawyer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 5/18/2000 Female 5/13/2008 Lawyer United States
Primary
Secondary

Drug Data